*Heron Bd to Evaluate Various Strategic Transactions for Use of Transaction Proceeds, Including Acquiring or Investing in Further Businesses or Assets, Which May or May Not Be Pharmaceutical or Biotechnology Businesses or Assets >CRMD HRTX

Dow Jones · 6d ago

Please log in to view news